Neurogene Inc. Operating Leases, Rent Expense
Neurogene Inc. (NGNE) reported Operating Leases, Rent Expense of $200.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-03-12
- Neurogene Inc. operating leases, rent expense for the quarter ending 2019-06-30 was $200.00K.
- Neurogene Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $0.00.
- Neurogene Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $300.00K.
- Neurogene Inc. operating leases, rent expense for the quarter ending 2018-03-31 was $200.00K.
- Neurogene Inc. operating leases, rent expense for fiscal 2018 was $700.00K, a 0.00% change from fiscal 2017.
- Neurogene Inc. operating leases, rent expense for fiscal 2017 was $700.00K, a 75.00% increase from fiscal 2016.
- Neurogene Inc. operating leases, rent expense for fiscal 2016 was $400.00K, a 100.00% increase from fiscal 2015.
- Neurogene Inc. operating leases, rent expense for fiscal 2015 was $200.00K, a 6.38% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-01 | $400.00K 10-Q · filed 2019-08-01 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $300.00K derived: sum of 2 quarters · filed 2020-03-12 | $700.00K 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $300.00K 10-Q · filed 2019-11-13 | $700.00K 10-Q · filed 2019-11-13 | |||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-07 | ||||
| 2017-12-31 | $700.00K 10-K · filed 2020-03-12 | ||||
| 2016-12-31 | $400.00K 10-K · filed 2019-03-07 | $370.00K 10-K · filed 2017-03-09 | |||
| 2015-12-31 | $200.00K 10-K · filed 2018-03-12 | $154.00K 10-K · filed 2017-03-09 | |||
| 2014-12-31 | $188.00K 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |